C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes

Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2002
10/24/2002	WO2002083851A2 Vegf fusion proteins
10/24/2002	WO2002083844A2 Compositions and methods for the production of betaine lipids
10/24/2002	WO2002083727A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid
10/24/2002	WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083706A1 Nucleic acid encoding a human adenylosuccinate synthetase
10/24/2002	WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	WO2002083182A2 The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification
10/24/2002	WO2002083180A1 Elongated and multiple spacers in activatible prodrugs
10/24/2002	WO2002083179A2 Fusion proteins
10/24/2002	WO2002083159A1 Palliative effects of morinda citrifolia oil and juice
10/24/2002	WO2002083064A2 A method of treating cancer
10/24/2002	WO2002083030A2 Bifunctional energy-reversible acyl-compositions
10/24/2002	WO2002082889A1 A method to control the ripening of papaya fruit and confer disease resistance to papaya plants
10/24/2002	WO2002070674A3 A human member of the phospholipase d superfamily and methods for regulating its activity
10/24/2002	WO2002061061A3 Inhibition of interleukin-1-beta secretion by card proteins
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002057226A9 68730 and 69112 protein kinase molecules and uses therefor
10/24/2002	WO2002055669A3 Regulation of target protein activity through modified proteins
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	WO2002045524A3 Prolyl endoprotease from aspergillus niger
10/24/2002	WO2002044352A9 Bacteriolytic complex, method for producing said complex and strain for carrying out said method.
10/24/2002	WO2002038739A3 Bacterial expression systems
10/24/2002	WO2002034896A3 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
10/24/2002	WO2002026958A3 Human neprilysin protease
10/24/2002	WO2002022830A3 Transglutaminase gene products
10/24/2002	WO2002022777A3 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
10/24/2002	WO2002016569A3 38618, a human alpha/beta hydrolase and uses thereof
10/24/2002	WO2002010425A3 Ascorbic acid production from yeasts
10/24/2002	WO2002002761A3 57658, a human uridine kinase and uses thereof
10/24/2002	WO2002000913A9 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2
10/24/2002	WO2001073052A3 Thermophilic polymerase iii holoenzyme
10/24/2002	WO2001073038A3 Method for the biotechnological production of l-alaninol
10/24/2002	WO2001064861A3 Phosphoribosyl pyrophosphate synthetase 1 as herbicidal target
10/24/2002	WO2001059103A9 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
10/24/2002	WO2001059075A9 Improved sialylation of glycoproteins
10/24/2002	WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/24/2002	WO2001049865A9 Fermentative production of ethanol by heterologous expression of a pyruvate decarboxylase gene in bacillus sp
10/24/2002	US20020157132 Polynucleotide that encodes a plant cysteine gamma synthase
10/24/2002	US20020157123 Compositions and methods for treating enzyme deficiency
10/24/2002	US20020157122 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof
10/24/2002	US20020157121 Propagation of human hepatocytes in non-human animals
10/24/2002	US20020156773 Soluble HLA ligand database utilizing predictive algorithms and methods of making and using same
10/24/2002	US20020156585 Crystallization and structure determination of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (S. aureus MurB)
10/24/2002	US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders
10/24/2002	US20020156262 Polypeptides having lysophosphatidic acid acyltransferase activity and polynucleotides encoding polypeptides having LPAAT activity
10/24/2002	US20020156259 Human adenosine deaminase
10/24/2002	US20020156254 Nucleotide sequences coding polypeptide for use in the treatment of stress, diabetes, cancer, inflammatory and cardiovascular disorders
10/24/2002	US20020156240 Alpha-agarase and process for producing the same
10/24/2002	US20020156110 Anticancer, antiproliferative and antiarthritic agents
10/24/2002	US20020156100 1-deoxy-galactonojirimycin and related compounds used to treat fabry disease
10/24/2002	US20020156089 Use of CRF antagonists and related compositions
10/24/2002	US20020156061 Administering to a mammal a matrix metalloproteinase inhibiting amount of derivatives of isophthalic acid, isophthalic acid ester or isothalamide compounds to treat cancer, rheumatic arthritis atherosclerosis and osteoporosis
10/24/2002	US20020156042 Human suppressor tRNA oligonucleotides and methods of use for same
10/24/2002	US20020156032 Inhibition of DNA methyltransferase
10/24/2002	US20020156012 Polypeptide containing the JAB subunit or the JAM domain has peptidase activity, e.g., isopeptidase activity.
10/24/2002	US20020156006 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/24/2002	US20020156005 m32404, a novel human trypsin and uses thereof
10/24/2002	US20020156004 Polypeptides having significant homology to the prolactin receptor protein
10/24/2002	US20020156000 Inhibiting NF-kappa B-dependent target gene expression in a cell.
10/24/2002	US20020155972 Detergent compositions comprising benefit agents
10/24/2002	US20020155608 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
10/24/2002	US20020155605 Expression vector for use as tool in controlling gene expression in plants
10/24/2002	US20020155602 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
10/24/2002	US20020155596 Recombinant vaccinia virus incorporated with gene coding glutamic acid decarboxylase and vaccine for preventing type 1 diabetes mellitus comprising the same
10/24/2002	US20020155579 Membrane derived caspase-3, compositions comprising the same and methods of use therefor
10/24/2002	US20020155575 Enzymatic polypeptide for use in laundering detergents
10/24/2002	US20020155574 Enzymatic polypeptide for use in detergents, textile treatment and desizing
10/24/2002	US20020155573 Cod uracil-DNA glycosylase, gene coding therefore, recombinant DNA containing said gene or operative parts thereof, a method for preparing said protein and the use of said protein or said operative parts thereof in monitoring or controlling PCR
10/24/2002	US20020155572 Peptide for use in diagnosis and treatment of alzheimier's disease
10/24/2002	US20020155571 Triazine degrading enzymes
10/24/2002	US20020155570 Nucleotide sequences coding polypeptide for use in the prevention, treatment of cancer
10/24/2002	US20020155568 Enzymatic polypeptide for use in animal feeds and food processing
10/24/2002	US20020155567 Glycosyltransferase gene gtfE from amycolatopsis oreintalis
10/24/2002	US20020155566 Process for delaying the deactivation of glutaryl amidase during enzyme catalysis
10/24/2002	US20020155562 Glutathionylspermidine synthetase and processes for recovery and use thereof
10/24/2002	US20020155560 Reductase
10/24/2002	US20020155555 Genetically engineered bacteria for use in the generation of preferential amino acids for use in human and animal medicine and nutrients
10/24/2002	US20020155550 Heat stable enzymes for use in food processing and textile treatment
10/24/2002	US20020155536 Expression cloning in filamentous fungi
10/24/2002	US20020155535 Novel human cysteine protease
10/24/2002	US20020155525 Expression vector for use in generation of preferential polypeptides in culture
10/24/2002	US20020155499 Nucleotide sequences coding polypeptides for use in the treatment of tumors, autoimmune inflammatory and Paget's disease
10/24/2002	US20020155497 Nucleotide sequences coding polypeptide for use in the treatment of Alzheimer's, myasthenia gravis, and vision diseases
10/24/2002	US20020155489 Generating libraries of nucleotide sequence clones; obtain cells, extract nucleotide sequences, digest sequence, incubate with expression vector, digest, ligate, transform cell, propgate, recover clonal library
10/24/2002	US20020155486 Apparatus for use in the storage of nucleotide sequence information
10/24/2002	US20020155460 Information rich libraries
10/24/2002	US20020155453 Method for generating diversity
10/24/2002	US20020155431 Screenining and detection of antiproliferative agentst; obtain tumor cells, incubate with antiproliferative agents, monitor reduction in tumor activity
10/24/2002	US20020155179 Integrin enzyme inhibitor
10/24/2002	DE10119905A1 Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway
10/24/2002	DE10119432A1 New nucleic acid encoding flavone synthase I, useful e.g. for preparing transgenic plants with altered flavone content, also derived enzyme used for flavone production
10/24/2002	DE10119005A1 Verfahren zur Proteinexpression ausgehend von stabilisierter linearer kurzer DNA in zellfreien in vitro-Transkription/Translations-Systemen mit Exonuklease-haltigen Lysaten oder in einem zellulären System enthaltend Exonukleasen A process for protein expression from stabilized linear short DNA comprising, in cell-free in vitro transcription / translation systems using exonuclease-containing lysates or in a cellular system exonucleases
10/24/2002	DE10113604A1 Verfahren zur Spaltung des humanen Wachstumshormons GH A process for cleavage of human growth hormone GH
10/24/2002	CA2456736A1 Compositions and methods for the production of betaine lipids
10/24/2002	CA2445029A1 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/24/2002	CA2444262A1 Bifunctional energy-reversible acyl-compositions
10/24/2002	CA2444026A1 Mutants of desoxycytidine kinase having extended enzymatic activity
10/24/2002	CA2443908A1 Product and process for transformation of thraustochytriales microorganisms
10/24/2002	CA2443903A1 Antibodies to vla-1

1 ... 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 ... 1416